The granularity of the GDM treatment data meant that we were able to not only compare OGDM‐Metformin to OGDM‐Insulin but also OGDM‐Metformin, OGDM‐Insulin and OGDM‐Lifestyle to No‐GDM. The gene discussed is INS; the disease is gestational diabetes.